Stay updated with breaking news from Erytech Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ERYTECH Pharma S.A. (NASDAQ:ERYP – Get Rating) was the recipient of a large decline in short interest in March. As of March 31st, there was short interest totalling 33,900 shares, a decline of 11.0% from the March 15th total of 38,100 shares. Based on an average trading volume of 33,900 shares, the days-to-cover ratio is […]
ERYTECH Pharma (NASDAQ:ERYP – Get Rating) and Vigil Neuroscience (NASDAQ:VIGL – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations. Earnings & Valuation This table compares ERYTECH Pharma and […]
Proposed strategic combination with Erytech Pharma intending to create a global leader in phage therapies: Acceleration in the development of phage therapy in antimicrobial resistance
/PRNewswire/ -- Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2023-2027 The analyst has been monitoring the diffuse large B-Cell Lymphoma...
This capital increase, fully subscribed by Auriga IV Bioseeds, Ouest Ventures III and the pool of shareholders represented by Guy Rigaud, historical shareholders of Pherecydes Pharma, is part of